GlassScriptPhysician profile
Eli Christopher Garrard
NPI 1700142379
$10,369.56
in general payments reported to CMS, 2019-2025
7 companies · $2,983 in 2025
The $2,983 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,807 · 2020: $796 · 2021: $440 · 2022: $292 · 2023: $1,929 · 2024: $122 · 2025: $2,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,402 · Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,401.62 |
| Food and Beverage | $632.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,170.06 | 2021-2025 | Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology, Unid_pass |
| Stryker Corporation | $3,788.22 | 2019-2022 | |
| Medtronic USA, INC. | $796.23 | 2020 | |
| Spineology INC. | $362.80 | 2021 | |
| Smith+Nephew, INC. | $117.20 | 2019 | |
| Misonix INC | $96.50 | 2019 | |
| Highridge Medical LLC | $38.55 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eli Garrard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.